CCP
IRWD icon

Clough Capital Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Clough Capital Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-753,056
Closed -$8.17M – 201
2014
Q3 		$8.17M Sell
753,056
-885,351
-54% -$10.1M 0.31% 97
2014
Q2 		$21M Buy
1,638,407
+508,167
+45% +$5.53M 0.66% 61
2014
Q1 		$11.7M Buy
1,130,240
+334,917
+42% +$3.77M 0.36% 93
2013
Q4 		$7.73M Sell
795,323
-809,532
-50% -$7.27M 0.25% 120
2013
Q3 		$15.9M Buy
+1,604,855
New +$15.7M 0.49% 89

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Clough Capital Partners's IRWD Position: Q4 2014 in Review

Clough Capital Partners sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2014, closing a stake of 753,056 shares — an estimated $8.17M sold.

Clough Capital Partners first reported a position in IRWD in Q3 2013 and held it in 5 quarters. The position peaked at $21M in Q2 2014. 129 funds tracked by Wall St. Rank hold IRWD as of Q4 2014.

  • Clough Capital Partners reported no remaining Ironwood Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Clough Capital Partners sold 753,056 Ironwood Pharmaceuticals shares in Q4 2014, an estimated $8.17M.
  • Clough Capital Partners first reported a position in Ironwood Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • Clough Capital Partners's Ironwood Pharmaceuticals position peaked at $21M in Q2 2014.
  • 129 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2014.

Based on Clough Capital Partners's 13F filing for Q4 2014, filed 17 Feb 2015.